Latest news from Cochrane
Common gout drug may reduce risk of heart attack and stroke
12 Noviembre 2025
A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.
Setting the standards for responsible AI use in evidence synthesis
11 Noviembre 2025
Cochrane, the Campbell Collaboration, JBI, and the Collaboration for Environmental Evidence have published a joint position statement on the responsible use of artificial intelligence (AI) in evidence synthesis.
GLP-1 drugs effective for weight loss, but more independent studies needed
30 Octubre 2025
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions.
What is Cochrane doing to strengthen research integrity?
29 Octubre 2025
We continue to lead the field in trustworthiness and transparency by evolving our practices to address the most pressing challenges in research integrity and publishing ethics, and to respond to rapid advances in technology. Here is a wrap up of recent developments in these areas.
Strong evidence supports skin-to-skin contact after birth as standard care
22 Octubre 2025
Immediate skin-to-skin contact between newborns and their mothers offers a better start in life, improving a number of key health metrics, according to a newly-updated Cochrane review.
World Evidence-based Healthcare Day promotes collaborative knowledge communication
20 Octubre 2025
This year, World Evidence-based Healthcare Day is focusing on exchanging information and ideas in creative and collaborative ways.
The role of trusted evidence in fighting vaccine disinformation
16 Octubre 2025
Cochrane joined global health leaders at the World Health Summit’s Academic Alliance session on confronting disinformation in the global anti-vaccine discourse. Together, they discussed how disinformation continues to undermine vaccine confidence and threaten public health worldwide.
Our daughters, our future: Pakistan’s HPV vaccination campaign offers hope
10 Octubre 2025
October 11th marks International Day of the Girl Child, a day that calls for policies that protect girls’ rights and enable their leadership. Pakistan recently introduced the human papilloma virus (HPV) vaccine for girls, aiming for a 90% vaccination rate. Dr Muhammad Tayyab Qureshi, from Cochrane Pakistan, reflects on the vaccine campaign so far, and the value of investing in girl’s futures.
WHO launches global clinical trials forum
3 Octubre 2025
The World Health Organization has launched the Global Clinical Trials Forum, a global, multi-stakeholder network to strengthen clinical trial environments and infrastructure at national, regional and global levels. Cochrane is pleased to be a member of this initiative.
Hear from Cochrane’s new Chief Executive Officer
2 Octubre 2025
In this video, Karla shares her vision for creating an evidence ecosystem that is fast, fair and fit for the future, with collaboration at the heart of this. Watch to find out more.
Our newsletters
Get regular news about different areas of our work in your inbox. Sign up for a Cochrane account and opt into newsletters in the 'Communications' tab to subscribe.
- Patient and Public Network newsletter: monthly digest for patients and members of the public about health evidence, and helping to create it
- Early Career Professionals Network newsletter: regular resources, training, events, opportunities, features and blogs relevant to Early Career Researchers
- Author Digest: monthly updates and tips on writing systematic reviews
- Cochrane Evidence Synthesis and Methods journal: sign up for alerts on our publisher's website
- Cochrane Library newsletter: updates on new Cochrane Library features, enhancements and the latest evidence. Sign up on our publisher's website.
Media enquiries
Please see our Press office page.
